GLAXOSMITHKLINE PLC ORD 25P

SelectedAlpha

Glaxosmithkline ($GSK) testing the golden resistance level 1431.5 standing outside of the upper daily Bollinger Band. This level previously reversed Glaxosmithkline down in December of 2020 and in January of this year. Selected Alpha ranks the reversal factor of this resistance level 25 points – making it the strongest golden tracked by the system at the moment....

Casvanick

Long overdue?

andmk2

Bottom of the range looks a good place to buy GSK. Underperforming though and needs some impetus for share price growth.

giles_t_error

Amature trader here. There is a strong pattern on GSK which is now in wave IV of an ending diagonal. Price should go to 1170 but buy around 1200 to show confirmation of a new uptrend. See here: This is a weekly chart but over the next two years it may go up 660pts to 1900, could be worth a look this is not investment...

FiguringOutFinance

One to key an eye on...

DOAFK

I previously posted a longterm stock position that I added to my portfolio. This was GSK (GlaxoSmithKline) which is trading at the lower levels of its range and has good growth potential but also a sturdy dividend yield of more than 5% each year. This stock has seen some strong bullish momentum this week and has broken out of a consolidation structure. The...

abel11

I would have expected a bull run immediately but because of the flat formation now, there might be a one wave drop before the bull run. thanks for the support. This market to me is bullish.

Deevog

GSK London a good buy in many ways In Long Term (For Months) In Short Term (Days to Week) Nice Dividend Best

DOAFK

GSK is trading around the multi year lows having bounced off of the long term support zone at 1300. I think this is a relative bargain at these levels with GSK being one of the Big Pharma Companies that is still trading way below the starting price for the year. Pfizer, Johnson & Johnson and Roche are all either positive or around net zero YTD. Novartis is...

NN-trading

#GSK is likely to begin impulse Wave 3. Buy at 1380, TP 1555, SL 1320

F_Investments

LSE:GSK - Double bottom at GBX 1,330 - Divergence RSI/Price - MACD sloping up - Trend line broken - Target price GBX 1,600 What do you think?

XJ19YDN

Very undervalued UK company, strong foundations Looking at the 1400 level or potentially lower

YL_PRO

Hi friends the weekly chart of this market shows that it will experience a downtrend but also we must be vigilant of the change towards the opposite direction please subscribe to receive more analyzes

andmk2

Pressure is building and a breakout could be imminent. It's taken 6 years from May 2013 where the high was 1816 Needs substantive news to make the push over the 1750s

yussray

GSK is in strong trending in all TF. Looking positive in days to come Price today at 1742.

optimystery

GSK is showing a macro uptrend. Bearish divergence showing on the MACD and RSI. I have marked the previous divergence also, which preceded a sharp fall. We may be coming down to test the support line. The 2007-2009 dip is shown (38%)

Investamate

SELL – GLAXOSMITHKLINE (GSK) GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. Fundamentals...

benjshaw

Gsk is likely to continue to raise I predict it will go up to 4.5% this year.